Financials

News Discussions Technicals Forecast Seasonals

KAPA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Kairos Pharma, Ltd. operating, investing, and financing activities

KAPA free cash flow for Q2 24 is -168 k USD. For 2023, KAPA free cash flow was 81 k USD and operating cash flow was 81 k USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—